Skip to search.
 TSX Down 0.67% TSX Ventures Up 0.03%

Gilead Sciences Inc. (GILD)

-NasdaqGS
81.37 Down 0.15(0.18%) Sep 23, 4:00PM EDT
|After Hours : 81.39 Up 0.02 (0.02%) Sep 23, 7:59PM EDT
Prev Close:81.52
Open:81.33
Bid:81.39 x 8300
Ask:81.51 x 200
1y Target Est:104.50
Beta:1.00055
Earnings Date:Oct 25 - Oct 31 (Est.)
Day's Range:81.22 - 82.00
52wk Range:76.67 - 111.11
Volume:7,534,538
Avg Vol (3m):10,680,600
Market Cap:107.38B
P/E (ttm):7.14
EPS (ttm):11.39
Div & Yield:1.88 (2.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 0.18%107.38B
GSKDown 0.37%105.53B
PFEUp 0.32%207.81B

Key Statistics

Forward P/E (1 yr):7.00
P/S (ttm):3.32
Ex-Dividend Date:14-Sep-16

Analysts

Annual EPS Est (Dec-16) :11.76
Quarterly EPS Est (Sep-16) :2.88
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-33.00

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback